Patents by Inventor Charles L. Sawyers

Charles L. Sawyers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mice models of human prostate cancer progression
    Publication number: 20020138861
    Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
    Type: Application
    Filed: January 30, 2002
    Publication date: September 26, 2002
    Applicant: The Regents of the University of California
    Inventors: Charles L. Sawyers, Karen A. Klein, Owen N. Witte, Robert E. Reiter
  • Methods of assessing the effect of a gene of interest on human prostate cancer progression
    Publication number: 20020133833
    Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
    Type: Application
    Filed: January 30, 2002
    Publication date: September 19, 2002
    Applicant: The Regents of the University of California
    Inventors: Charles L. Sawyers, Karen A. Klein, Owen N. Witte, Robert E. Reiter
  • Methods of assessing the effect of a gene of interest on human prostate cancer progression
    Publication number: 20020129390
    Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
    Type: Application
    Filed: January 30, 2002
    Publication date: September 12, 2002
    Applicant: The Regents of the University of California
    Inventors: Charles L. Sawyers, Karen A. Klein, Owen N. Witte, Robert E. Reiter
  • Methods of simulating human prostate cancer progression
    Publication number: 20020108135
    Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
    Type: Application
    Filed: January 30, 2002
    Publication date: August 8, 2002
    Applicant: The Regents of the University of California
    Inventors: Charles L. Sawyers, Karen A. Klein, Owen N. Witte, Robert E. Reiter
  • Mice models of human prostate cancer progression
    Publication number: 20020083478
    Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
    Type: Application
    Filed: December 14, 2001
    Publication date: June 27, 2002
    Applicant: The Regents of the University of California
    Inventors: Charles L. Sawyers, Karen A. Klein, Owen N. Witte, Robert E. Reiter
  • Mice models of human prostate cancer progression
    Patent number: 6365797
    Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: April 2, 2002
    Assignee: The Regents of the University of California
    Inventors: Charles L. Sawyers, Karen A. Klein, Owen N. Witte, Robert E. Reiter
  • Mice models of human prostate cancer progression
    Patent number: 6107540
    Abstract: The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
    Type: Grant
    Filed: October 15, 1997
    Date of Patent: August 22, 2000
    Assignee: The Regents of the University of California
    Inventors: Charles L. Sawyer, Karen A. Klein, Owen N. Witte, Robert E. Reiter
  • E25a protein, methods for production and use thereof
    Patent number: 6093800
    Abstract: The invention provides a human E25a protein which is upregulated in cancerous cells, including those of hormone refractory prostate cancer, colon cancer, breast cancer or other cancers of epithelial origin. The invention also provides nucleic acid molecules encoding E25a protein, nucleic acid probes which hybridize with nucleic acid molecules encoding E25a protein, and antibodies which bind E25a protein. E25a protein and its related molecules can be useful as diagnostic markers of cancer, including hormone refractory prostate cancer, and as specific therapeutic targets in this disease. The invention also provides methods for diagnosing cancer, including hormone refractory prostate cancer.
    Type: Grant
    Filed: September 5, 1997
    Date of Patent: July 25, 2000
    Assignee: The Regents of the University of California
    Inventors: Robert E. Reiter, Owen N. Witte, Charles L. Sawyers